Filing Details

Accession Number:
0001179110-10-011405
Form Type:
4
Zero Holdings:
No
Publication Time:
2010-07-06 13:00:00
Reporting Period:
2010-07-01
Filing Date:
2010-07-06
Accepted Time:
2010-07-06 14:25:53
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1222244 Prourocare Medical Inc. PUMD Surgical & Medical Instruments & Apparatus (3841) 201212923
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
901152 L James Davis 6446 Flying Cloud Dr
Eden Prairie MN 55344
Yes No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, $0.00001 Par Value Acquisiton 2010-07-01 3,021 $1.60 1,808,897 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock, $0.00001 Par Value 74,964 Indirect Held by "Davis & Associates 401K PSP"
Common Stock, $0.00001 Par Value 37,482 Indirect Held by "Davis & Associates Inc."
Reported Derivative Holdings
Sec. Name Sec. Type Price Date Expiration Date Amount Remaning Holdings Nature of Ownership
Common Stock, $0.00001 Par Value Warrants $5.00 2010-02-28 15,625 15,625 Direct
Common Stock, $0.00001 Par Value Warrants $5.00 2010-03-21 1,702 1,702 Direct
Common Stock, $0.00001 Par Value Warrants $5.00 2012-12-27 5,800 5,800 Direct
Common Stock, $0.00001 Par Value Warrants $5.00 2012-12-27 6,050 6,050 Indirect
Common Stock, $0.00001 Par Value Warrants $5.00 2012-12-27 700 700 Indirect
Common Stock, $0.00001 Par Value Warrants $1.50 2013-04-03 25,000 25,000 Direct
Common Stock, $0.00001 Par Value Warrants $0.50 2012-12-31 30,000 30,000 Direct
Common Stock, $0.00001 Par Value Warrants $0.70 2012-12-31 30,000 30,000 Direct
Common Stock, $0.00001 Par Value Warrants $0.70 2012-12-31 10,000 10,000 Indirect
Common Stock, $0.00001 Par Value Warrants $0.70 2012-12-31 5,000 5,000 Indirect
Common Stock, $0.00001 Par Value Warrants $1.00 2012-12-31 30,000 30,000 Direct
Common Stock, $0.00001 Par Value Warrants $1.50 2013-09-25 100,000 100,000 Direct
Common Stock, $0.00001 Par Value Warrants $2.00 2009-10-31 2013-10-31 16,667 16,667 Direct
Common Stock, $0.00001 Par Value Warrant $1.30 2009-02-06 2014-01-07 314,846 314,846 Direct
Common Stock, $0.00001 Par Value Warrants $1.30 2009-02-06 2014-01-07 224,890 224,890 Direct
Common Stock, $0.00001 Par Value Warrants $1.30 2009-02-06 2014-01-07 74,964 74,964 Indirect
Common Stock, $0.00001 Par Value Warrants $1.30 2009-02-06 2014-01-07 37,482 37,482 Indirect
Common Stock, $0.00001 Par Value Warrants $1.30 2009-02-06 2014-01-07 195,000 195,000 Direct
Common Stock, $0.00001 Par Value Options $2.41 2017-03-01 10,374 10,374 Direct
Cash Promissory Note $1.00 2010-07-11 0 0 Direct
Cash Promissory Note $1.00 2010-07-11 0 0 Indirect
Cash Promissory Note $1.00 2010-07-11 0 0 Indirect
Common Stock Loan Guarantee Agreement $0.00 2011-03-28 95,555 95,555 Direct
Expiration Date Amount Remaning Holdings Nature of Ownership
2010-02-28 15,625 15,625 Direct
2010-03-21 1,702 1,702 Direct
2012-12-27 5,800 5,800 Direct
2012-12-27 6,050 6,050 Indirect
2012-12-27 700 700 Indirect
2013-04-03 25,000 25,000 Direct
2012-12-31 30,000 30,000 Direct
2012-12-31 30,000 30,000 Direct
2012-12-31 10,000 10,000 Indirect
2012-12-31 5,000 5,000 Indirect
2012-12-31 30,000 30,000 Direct
2013-09-25 100,000 100,000 Direct
2013-10-31 16,667 16,667 Direct
2014-01-07 314,846 314,846 Direct
2014-01-07 224,890 224,890 Direct
2014-01-07 74,964 74,964 Indirect
2014-01-07 37,482 37,482 Indirect
2014-01-07 195,000 195,000 Direct
2017-03-01 10,374 10,374 Direct
2010-07-11 0 0 Direct
2010-07-11 0 0 Indirect
2010-07-11 0 0 Indirect
2011-03-28 95,555 95,555 Direct
Footnotes
  1. Currently exercisable
  2. Reporting person is the Sole owner of Davis & Associates Inc. and has sole voting power.
  3. The warrants were purchased as part of as a Unit at a price of $1.00 per unit. Each unit consisted of one share of $0.00001 par value common stock and one redeemable five-year warrant to purchase one share of common stock at $1.30 per share. The warrants became exercisable and separately transferable from the shares of common stock on February 6, 2009.
  4. Options vest as to 433 shares per month for 23 months beginning April 1, 2010 and as to 415 shares on March 1, 2012.
  5. On June 11, 2010, the Company executed a promissory note in the principal amount of $130,000 with a maturity date of December 1, 2010, with interest to accrue daily and payable in Warrants through July 10, 2010. (the "Note"). Warrants will accrue at a rate of 333.333 shares of common stock per day up to a maximum warrant coverage of 10,000 shares of common stock per $13,000 original principal amount of Notes, which equals a maximum warrant of 100,000 shares of common stock with respect to the Note. After 30 days, the Note will bear interest payable in cash and Warrants representing the accrued interest will be issued at an exercise price of $1.30.
  6. On June 11, 2010, the Company executed a promissory note in the principal amount of $26,000 with a maturity date of December 1, 2010, with interest to accrue daily and payable in Warrants through July 10, 2010. (the "Note"). Warrants will accrue at a rate of 333.333 shares of common stock per day up to a maximum warrant coverage of 10,000 shares of common stock per $13,000 original principal amount of Notes, which equals a maximum warrant of 20,000 shares of common stock with respect to the Note. After 30 days, the Note will bear interest payable in cash and Warrants representing the accrued interest will be issued at an exercise price of $1.30.
  7. On June 28, 2010, the issuer entered into a loan guarantee agreement pursuant to which the reporting person will be issued up to 95,555 shares of issuer's common stock as compensation for guaranteeing $1,000,000 of issuer's bank debt through November 30, 2011 and $900,000 of bank debt from December 1, 2010 through March 28, 2011. Reporting person will receive 11,111 shares per month for five months, and 10,000 shares a month for four months. A minimum amount six months'compensation will be paid to the reporting person.
  8. Issed to reporting person in lieu of cash for director's fees.